Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Immunotherapy × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Neoplasm Metastasis 7 Lung Neoplasms 7 Esophageal Neoplasms 7 Melanoma 6 Breast Neoplasms 5 Stomach Neoplasms 4 Neoplasms 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Pathologic Complete Response 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Carcinoma 2 Breast Neoplasms, Male 2 Unresectable Hepatocellular Carcinoma 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Solid Tumor Cancer 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Radiation Injuries 1

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡